Jabra Enhance Select 200 vs Otofonix Groove

The Jabra Enhance Select 200 is a premium-priced OTC hearing aid that earns a B grade with a SoundScore of 3.9/5 in our lab testing, ranking in the top 35% of OTC devices. At $1,695, it sits at the higher end of the OTC market and has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. This behind-the-ear device delivers its strongest performance in speech clarity during quiet environments, scoring 3.5/5—a solid result that sits 0.67 points above the OTC category average. Own-voice comfort is another highlight at 3.4/5, which is 0.89 points above average, meaning wearers are less likely to experience the bothersome "talking in a barrel" sensation. Music streaming scores 2.6/5, which is 0.68 points above the category average, though still mixed in absolute terms. The device shows some limitations in challenging listening situations. Speech in noise performance is low at 1.4/5, sitting slightly below the category average. Feedback handling scores a strong 4.0/5 in absolute terms, though this falls 0.54 points below the OTC average of 4.54/5. The Enhance Select 200 includes modern conveniences like rechargeable batteries and streaming compatibility with both iPhone and Android devices, plus hands-free calling capability. However, budget-conscious shoppers should note that several devices in this price range—including the Lucid Tala and Audicus Omni 2—achieve higher scores, and alternatives like the Lucid Engage offer similar sound quality at lower prices. This device is best suited for listeners who prioritize clear speech in quieter settings and natural own-voice quality over performance in noisy environments.

The Otofonix Groove is a behind-the-ear prescription hearing aid priced at $795, earning a C grade with a SoundScore of 2.7/5 in our lab testing. This rechargeable BTE device ranks 36th out of 36 tested prescription hearing aids, placing it in the bottom tier of its category. In our testing, the Groove demonstrated one clear strength: excellent feedback handling at 5.0/5, scoring 0.29 points above the category average. The device remained stable during our standardized challenge motions with no audible feedback issues. However, speech performance was significantly limited, with both speech in quiet and speech in noise scoring 1.0/5—falling 2.32 and 0.96 points below their respective category averages. Music streaming quality scored 0.0/5, which is 2.64 points below the prescription category average. Own-voice comfort was also low at 0.4/5 in the tuned configuration, 2.35 points below average, suggesting notable occlusion-related concerns. The normalized Initial Score of 2.7/5 and Tuned Score of 2.6/5 indicate that professional fitting adjustments did not improve overall performance. Given its positioning at the bottom of the prescription hearing aid category and the availability of lower-priced alternatives that scored higher in our testing, the Otofonix Groove may be difficult to recommend for most users seeking balanced sound quality across listening situations.